← Latest papers
🧬 biology

Genomic Dissection of Virulence, Resistance, and Evolution in Colonizing versus Infected Klebsiella pneumoniae Isolates

This study demonstrates that while *Klebsiella pneumoniae* isolates colonizing preoperative cardiac surgery patients share clonal backgrounds with those causing invasive infections, the latter are significantly enriched for hypervirulent features, particularly the ST23-K1 clone and the *rmpA2* regulator, suggesting that high-risk colonizing clones may evolve into severe infections.

Original authors: Xiaoyu Zhang, Sufei Tian, Yunfeng Shi, Deng Zhang, Xifan Zhang, Dan Li, Bing Bing Liu, Yunzhuo Chu, Jingping Zhang, Xin Zhang

Published 2026-09-16
📖 5 min read🧠 Deep dive

Original authors: Xiaoyu Zhang, Sufei Tian, Yunfeng Shi, Deng Zhang, Xifan Zhang, Dan Li, Bing Bing Liu, Yunzhuo Chu, Jingping Zhang, Xin Zhang

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Inside the human body, a quiet war is often fought between harmless bacteria that live on our skin and in our noses, and the same bacteria when they turn into dangerous invaders. One of the most common residents in this microscopic world is a germ called Klebsiella pneumoniae. For most people, this bacterium is just a passenger, living quietly in the throat or gut without causing any trouble. However, for some, particularly those who are very sick or undergoing major surgery, this same passenger can cross a barrier, enter the bloodstream, and cause severe, life-threatening infections. Scientists have long wondered what makes the difference between a harmless colonizer and a deadly invader. Is it a specific genetic switch that flips when the bacteria enter the body? Or do the bacteria that cause disease simply happen to be the same ones that were already living there, waiting for a chance to strike? Understanding this distinction is vital for doctors, because if they know which bacteria are likely to cause trouble, they might be able to screen patients before surgery and prevent infections before they start.

A team of researchers from several hospitals in China set out to solve this puzzle by looking at the genetic blueprints of Klebsiella pneumoniae. They focused on patients scheduled for heart surgery, a group at high risk for infections. Before the operations began, the team took swabs from the throats of over two thousand patients to see what bacteria were living there. They found that Klebsiella pneumoniae was the most common germ present, living in the throats of nearly one in five patients. From this massive pool, the researchers selected a specific group of bacteria to study in detail: thirty-two samples taken from patients who were simply carrying the germ without being sick, and thirty-six samples taken from patients who had developed serious infections in their blood, spinal fluid, or joints during the same time period. By comparing the complete genetic code of these two groups, the scientists hoped to find the molecular fingerprints that separate a harmless resident from a dangerous attacker.

The first thing the researchers discovered was that the bacteria causing the infections were not necessarily more resistant to antibiotics than the ones just living in the throat. In fact, most of the bacteria in both groups were still easily killed by standard medicines. This ruled out the idea that the dangerous bacteria were simply the "superbugs" that had evolved to survive drugs. Instead, the difference lay in their identity and their internal machinery. The bacteria found in the sick patients belonged to a specific family, known by scientists as a sequence type, that was much more common in the infection group than in the colonizing group. Furthermore, these infection-causing bacteria were much more likely to carry a specific genetic code for a protective shell, called a capsule, which is known to help bacteria hide from the human immune system.

The study also looked at a physical trait that doctors often use to guess how dangerous a bacterium might be: its stickiness. Some bacteria produce a thick, gooey slime that allows them to stretch into long strings when touched with a loop, a test that has traditionally been used to spot highly virulent strains. The researchers found that this sticky trait was actually just as common in the harmless throat bacteria as it was in the dangerous infection bacteria. This suggests that the old method of looking for stickiness is not a reliable way to predict who will get sick. Instead, the researchers found that the infection bacteria were more likely to carry a specific genetic regulator, a sort of master switch, that controls how the bacteria behave. This switch, along with the specific family and protective shell mentioned earlier, appeared to be the true markers of the bacteria that were capable of causing invasive disease.

When the scientists built a family tree of all the bacteria they studied, including data from other labs around the world, a clear picture emerged. The bacteria living harmlessly in the throats and the bacteria causing severe infections were closely related, often belonging to the same genetic branches. This indicates that the infections did not come from a completely different, unknown source, but rather from the very bacteria that were already colonizing the patients' own bodies. The study suggests that for patients undergoing major surgery, the bacteria they carry in their throats can serve as a reservoir for future infection. If the body's defenses are weakened by the stress of surgery, these local residents can cross over and cause disease. The findings point toward a new way of thinking about patient care: rather than just treating infections after they happen, doctors might benefit from screening high-risk patients for these specific, dangerous genetic signatures before surgery begins. While the study does not prove that removing these bacteria will stop infections, it provides a strong reason to investigate whether targeted strategies to clear these specific strains could save lives.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →